Hematology TimesIxazomib improves PFS after ASCT in MMDecember 4, 2018Multiple MyelomaTransplantation
Hematology TimesOlder people with CHIP are safe donor source for HSCTNovember 27, 2018Transplantation
Hematology TimesElderly NHL patients have higher NRM after HSCTNovember 20, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive LymphomasFollicular LymphomaB Cell Lymphoma
Hematology TimesStudy supports PBM program for HSCT recipientsNovember 13, 2018Blood BankingTransplantation
Hematology TimesChanges related to AML relapse may be reversibleNovember 6, 2018Leukemia, Myelodysplasia, TransplantationTransplantationAML
Hematology Times‘Mechanoprimed’ MSCs aid hematopoietic recoveryOctober 25, 2018Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersTransplantation
Hematology Times‘Intense’ end-of-life care may be common in HSCT recipientsOctober 19, 2018AnemiaLeukemia, Myelodysplasia, TransplantationTransplantationAMLALLMyelodysplastic Syndrome
Hematology TimesUnderstanding the role of HSCT in PTCLOctober 17, 2018Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin Lymphoma
Hematology TimesFDA grants rezafungin QIDP and fast track designationsSeptember 28, 2018Transplantation
Hematology TimesPlacenta-derived product receives orphan designation for HSCTSeptember 27, 2018Transplantation
